Padraig Dixon
@padraigdixon.bsky.social
Health Economist | Nuffield Department of Primary Care Health Sciences, Oxford
Associate Director in Health Economics | Central and South Genomics Medicine Service Alliance
Research Fellow | Reuben College, Oxford
Associate Director in Health Economics | Central and South Genomics Medicine Service Alliance
Research Fellow | Reuben College, Oxford
Reposted by Padraig Dixon
(3/4) @padraigdixon.bsky.social (University of Oxford) will present a novel approach to estimate long-term cost-effectiveness of health interventions without RCTs/Markov models. Using a prostate cancer prevention case study, he’ll show how MR can link genetic liability to healthcare costs & QALYs.
September 3, 2025 at 9:34 AM
(3/4) @padraigdixon.bsky.social (University of Oxford) will present a novel approach to estimate long-term cost-effectiveness of health interventions without RCTs/Markov models. Using a prostate cancer prevention case study, he’ll show how MR can link genetic liability to healthcare costs & QALYs.